Back to Results
First PageMeta Content
Research / Pharmaceutical industry / Pharmaceuticals policy / Pharmacology / Food and Drug Administration / Regulatory requirement / Health Canada / Clinical trial / Health Products and Food Branch / Health / Clinical research / Medicine


Q1A(R2) - Stability Testing of New Drug Substances and Products
Add to Reading List

Document Date: 2013-07-12 14:26:04

Open Document

File Size: 74,76 KB

Share Result on Facebook

City

Ottawa / /

Company

ICH Expert Working Group / /

Country

Japan / United States / Canada / /

/

Facility

Publications Brooke Claxton Building / Pharmaceutical Sciences Therapeutic Products Directorate Health Canada Finance Building / /

/

IndustryTerm

on biotechnological/biological products / certain degradation products / drug product / health products / therapeutic product / likely degradation products / registration applications / degradation products / Drug products / food / clinical trial applications / /

MarketIndex

EGX 30 / /

Organization

Health Products and Food Branch / Therapeutic Products Directorate / Biologics and Genetic Therapies Directorate / Bureau of Pharmaceutical Sciences Therapeutic Products Directorate Health Canada Finance Building / European Union / /

/

Position

coordinator / Minister of Health / Minister of Public Works / General / /

Product

Case - 2.2.7.3 Drug / /

ProgrammingLanguage

EC / /

ProvinceOrState

Ontario / /

URL

http /

SocialTag